课题基金 / 基金详情

GHRH受体调节巨噬细胞在动脉粥样硬化中的作用

批准号:
82070448
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
余红
依托单位:
学科分类:
动脉粥样硬化与动脉硬化
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
余红

项目摘要

结项摘要

余红的其他基金

相似基金

相关文献

中文摘要
巨噬细胞在动脉粥样硬化中起关键作用。该细胞传统地被分为促炎的M1型和抑炎的M2型,其极化状态受AMPK活性调控。生长激素释放激素(GHRH)通过结合其受体(GHRH-R)而发挥生物学效应。我们发现作为G偶联蛋白受体一员的GHRH-R在M1型巨噬细胞高表达,在M2型低表达。GHRH-R能否影响巨噬细胞M1/M2亚型转换尚不明了。我们假设: GHRH-R激活抑制AMPK活性导致巨噬细胞炎性反应增多;应用GHRH拮抗剂抑制GHRH-R激活,提高AMPK活性,促进巨噬细胞向M2型极化,从而防止斑块形成。我们将通过LDLr-/-小鼠和髓系特异GHRH-R敲除小鼠杂交获得双敲小鼠构建动脉硬化模型,应用荧光探针技术明确巨噬细胞中GHRH-R对巨噬细胞极化和斑块形成的影响及作用机制。应用GHRH拮抗剂抑制GHRH-R,阐明GHRH-R调节巨噬细胞炎性能力的机理,明确GHRH拮抗剂对动脉粥样硬化的治疗作用。
英文摘要
Macrophages play a key role in atherosclerosis. According to its function, Macrophage is broadly categorized as “classically activated” pro-inflammatory M1 macrophages and “alternatively activated” anti-inflammatory M2 macrophages. Energy metabolism which is regulated by AMP-activated protein kinase (AMPK) is an important factor in regulating the phenotypic transformation of macrophages. Growth hormone releasing hormone (GHRH) exerts its biological effects by binding to its receptor (GHRH-R). We found that there is more GHRH-R expressed in M1 macrophages than that in M2 macrophages. However, whether GHRH-R can affect macrophage M1/M2 isoform conversion is unknown. We hypothesize that activation of GHRH-R enhances the production of cAMP, which inhibits AMPK activity and results in higher production of inflammatory factors and severer atherosclerosis; GHRH antagonist can inhibit the activation of GHRHR, therefore increase the activity of AMPK which enhances the lipid metabolic activity and promotes M2 polarization of macrophages, resulting in less plaque formation. We will hybridized LDLr-/- mice and myeloid specific GHRHR-/- knockout mice to create a double-knockout mouse, which will be used to establish an atherosclerotic model of mice. Then we will clarify the effect of GHRHR on polarization of macrophages and plaque formation. By such, GHRH antagonist will be applied to inhibit GHRH receptor to elucidate the role and mechanism of GHRH-R in regulating the inflammatory ability of macrophages and their lipid metabolic activity. The effects of GHRH-R on polarization of macrophage and development of atherosclerosis will be determined.
本项目研究了GHRH-R对巨噬细胞功能影响。巨噬细胞中GHRH-R表达水平可以调控炎性因子表达。,GHRH-R与EGFR的相互作用可激活PI3K/AKT通路,产生引起SIMD的炎症因子IL-1β。GHRH-R拮抗剂MIA602有效阻断GHRH-R与EGFR的相互作用,可减轻脓毒症引起的心肌功能障碍,提高小鼠生存率。我们还对肿瘤治疗合并心力衰竭的解决方案进行了探索。我们发现GHRH-A激动剂多肽可以缓解蒽环类药物(如DOX)诱导的心肌损伤,显著改善Dox-诱导心衰小鼠的生存率。GHRH-A通过调控GHRH/GHRH-R信号通路,抑制心肌细胞的铁死亡,保护心肌细胞。另外,我们创新设计并合成具有GHRH-R激活潜能的多肽,新型GHRH类似物多肽具有更好的稳定性和活性, 显著促进下肢缺血小鼠的血管新生,并成功创建可口服的GHRH多肽递送系统。为开发以GHRH-R为靶点的多肽新药开发奠定基础。
缺氧处理对骨髓间充质干细胞分泌exosome内含物的影响:瘦素的作用及机制
  • 批准号:
    81570251
  • 项目类别:
    面上项目
  • 资助金额:
    60.0万元
  • 批准年份:
    2015
  • 负责人:
    余红
  • 依托单位:
衰老对内皮祖细胞CXCR4表达及其促血管新生能力的影响
  • 批准号:
    31271585
  • 项目类别:
    面上项目
  • 资助金额:
    75.0万元
  • 批准年份:
    2012
  • 负责人:
    余红
  • 依托单位:
国内基金
海外基金